At-Home Pulmonology Infusion Therapy with AvevoRx
Infusion Therapy for Alpha-1 Antitrypsin Deficiency
Patients living with Alpha-1, or alpha-1 antitrypsin deficiency, lack AAT, a protein that protects the body’s tissues from being damaged while the immune system works to fight off infection. This rare deficiency can lead to lung disease like emphysema, a form of COPD, and in rare cases, liver scarring and panniculitis. Being diagnosed is the first step, and from there, the treatment journey can begin. AvevoRx is a limited distribution provider of Glassia®, Aralast® and Zemaira®, which can help stop the progression of disease in those with Alpha-1.
AvevoRx is proud to have one of the most experienced teams at treating Alpha-1. Advocates, reimbursement staff and nurses can help patients navigate treatment options, insurance authorizations and therapy management for this rare disease. With decades of healthcare experience, we treat patients in the comfort of their homes while providing the level of service, speed and simplicity they deserve.